Search Results 241-250 of 16579 for Nizatidine

  1. Ceftolozane and tazobactam (intravenous route) - Side effects & uses - Mayo Clinic

    Ceftolozane and tazobactam combination injection is used alone or in combination with metronidazole to treat complicated bacterial infections in many different ...

  2. Trifluridine and tipiracil (oral route) - Side effects & dosage - Mayo Clinic

    Trifluridine and tipiracil combination is used alone or in combination with bevacizumab to treat metastatic colorectal cancer (cancer of the colon or rectum ...

  3. Obiltoxaximab (intravenous route) - Side effects & uses - Mayo Clinic

    Obiltoxaximab injection is used together with antibiotics to treat inhalational anthrax. It is also used to prevent inhalational anthrax after a person is ...

  4. https://www.mayoclinic.org/spanish_procedure_concepts.xml

  5. Nitrous Oxide For Endoscopic Ablation of Refractory Barrett's Esophagus - Mayo Clinic

    About this study. The purpose of this multicenter, prospective, single arm, non-randomized clinical trial to evaluate the safety and efficacy of the C2 ...

  6. A Study to Evaluate Regional Radiotherapy in Biomarker Low-Risk Node Positive Breast Cancer - Mayo Clinic

    The purpose of this study is to compare the effects on low-risk breast cancer receiving usual care that includes regional radiation therapy, with receiving no ...

  7. Nicotine lozenge - Mayo Clinic

    Nicotine lozenges are tablets that contain a small amount of nicotine, which is absorbed through the lining of your mouth.

  8. Chlordiazepoxide and clidinium (oral route) - Side effects & dosage - Mayo Clinic

    Chlordiazepoxide and clidinium combination is used in combination with other medicines to treat stomach or bowel problems including peptic ulcers, irritable ...

  9. A Study to Evaluate Tazemetostat and Pembrolizumab to Treat Advanced Urothelial Carcinoma - Mayo Clinic

    Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...

  10. ASCENT-Study of Sacituzumab Govitecan in Refractory/Relapsed Triple-Negative Breast Cancer - Mayo Clinic

    This is an international, multi-center, open-label, randomized, Phase III study in patients with metastatic TNBC refractory or relapsing after at least 2 prior ...